PEAPACK GLADSTONE FINANCIAL CORP quarterly report, Q3 FY2013

Peapack-Gladstone Financial Corporation — Q3 2013 Form 10-Q

Reporting period: Quarter and nine months ended September 30, 2013. Unless stated otherwise, dollar amounts are in millions. Comparisons are with 2012 for income and cash-flow measures, and December 31, 2012 for balance-sheet measures.

Business context

The company operates banking and trust and investment businesses, primarily in New Jersey and nearby markets. Growth emphasized commercial real estate, particularly multifamily lending, and expansion under a strategic plan. Trust assets under administration were approximately $2.58 billion, up 20% year over year.

Financial performance and condition

MetricQ3 2013Q3 2012Nine months 2013Nine months 2012
Net interest income$13.37$12.85$38.25$38.64
Net interest income, tax-equivalent$13.53$13.00$38.70$39.13
Net interest margin, tax-equivalent3.28%3.50%3.26%3.52%
Net income$1.96$2.83$6.87$8.64
Diluted EPS$0.22$0.32$0.76$0.93
Provision for loan losses$0.75$0.75$2.10$3.75
Operating expenses$14.17$11.99$40.54$34.78

For the nine-month EPS comparison, 2012 net income available to common shareholders was $8.16 million after preferred dividends; there were no preferred dividends in 2013. Q3 annualized return on average assets was 0.45% and return on average common equity was 6.28%. Nine-month annualized returns were 0.55% and 7.35%, respectively.

Balance sheet at September 30: Total assets were $1.798 billion, up from $1.668 billion at year-end 2012. Loans were $1.397 billion, up $264.4 million; commercial mortgage loans rose to $680.8 million from $420.1 million. Deposits totaled $1.573 billion, up $56.1 million. Shareholders’ equity was $126.4 million versus $122.1 million.

Credit and funding: Allowance for loan losses was $14.1 million, or 1.01% of loans, compared with $12.7 million, or 1.12%, at year-end. Nonperforming assets declined to $9.65 million from $15.23 million; nonaccrual loans were $6.89 million. Total borrowings included $47.7 million of FHLB advances and $30.4 million of overnight borrowings, versus no overnight borrowings at year-end. Cash and cash equivalents were $39.5 million, down from $119.2 million.

Cash flow, nine months: Operating activities provided $29.5 million; investing activities used $231.7 million, principally reflecting $268.3 million of net loan growth; financing activities provided $122.5 million. Cash and cash equivalents decreased $79.7 million.

Capital and liquidity: The Bank’s Tier 1 and total risk-based capital ratios were 11.01% and 12.26%; its leverage ratio was 7.01%. Management reported these exceeded well-capitalized thresholds. The company reported $461.1 million of unused FHLB overnight borrowing commitments and $29.4 million of correspondent-bank commitments. A $0.05 per-share dividend was declared October 17, payable November 14, 2013.

Material changes and notable items

  • Q3 net income fell 30.6% year over year; nine-month net income fell 20.5%. Loan growth and higher trust fees supported income, but lower asset yields and increased expenses weighed on results.
  • Tax-equivalent NIM contracted 22 basis points in Q3 and 26 basis points year to date. Loan yields fell 41 basis points in both comparisons, while lower funding costs only partly offset the pressure.
  • Q3 salary and benefit expense included a $933,000 staff-restructuring accrual, with an estimated after-tax impact of $569,000, or about $0.06 per diluted share. Management attributed broader expense growth to the strategic plan, staffing, incentives, and related costs.
  • Nine-month results included a $930,000 provision on one OREO property, an estimated after-tax charge of $595,000, or about $0.07 per diluted share. The filing reports no OREO provision in Q3.
  • Trust department income rose 12.9% in Q3 and 10.0% year to date. Nine-month gains on loan sales were $1.66 million, including a $522,000 gain on the first-quarter sale of classified loans.
  • Available-for-sale securities had $2.53 million of gross unrealized losses at quarter-end, including a $599,000 loss on a single-issuer trust-preferred security rated Ba1. Management considered the losses temporary and recorded no other-than-temporary impairment.
  • Accumulated other comprehensive income fell to $0.72 million from $4.30 million, reflecting securities valuation changes; total comprehensive income for the nine months was $3.29 million.

Outlook, commentary, and risks

Management expected strategic-plan expenses to remain elevated and indicated that related revenue and profitability would generally lag expenses by several quarters. It also expected loan growth may require additional FHLB and other borrowings. No quantified earnings or revenue guidance was provided. Management stated that liquidity was sufficient for future needs and expected the Bank to remain well capitalized under Basel III phase-in requirements.

Key sensitivities include low interest rates and net interest margin pressure, competition for loans and deposits, credit quality and real-estate collateral values in the New Jersey and New York markets, concentration and growth in commercial real estate lending, and execution of the strategic plan. The filing also identifies regulatory and compliance costs, liquidity and funding access, cybersecurity and operational risks, and potential effects of economic weakness. The company’s interest-rate model estimated that an immediate sustained 200-basis-point increase would reduce year-one net interest income by about 6%, while a 100-basis-point decrease would reduce it by about 4%; management cautioned that model assumptions limit predictive precision.

Management reported effective disclosure controls and no material change in internal control over financial reporting during the quarter. It stated that the company was not engaged in interest-rate swaps at quarter-end, though ALCO had been authorized to use them.

Important facts for investors to verify

  • Whether commercial mortgage and multifamily loan growth continues without weakening underwriting or increasing concentrations and credit losses.
  • Whether lower asset yields continue to outpace reductions in deposit and other funding costs, and the resulting effect on NIM and earnings.
  • The outlook for strategic-plan spending, the restructuring accrual, and the timing and scale of revenue expected to offset those costs.
  • Whether the OREO property valuation, allowance adequacy, nonaccrual trends, and the below-investment-grade trust-preferred security require further charges.
  • How loan growth, falling cash balances, and increased borrowings affect liquidity, funding costs, and capital under changing market conditions.